Healthcare >> Analyst Interviews >> July 14, 2008

OUTLOOK FOR CANADIAN BIOTECHNOLOGY – NEIL MAROUKA – CANACCORD ADAMS INC.

TWST: Neil, we're half way through the year at this point. How has the Canadian

biotech group done relative to your expectations?

Mr. Maruoka: I think that the group has performed in line